Antimicrobial Agents Practice Questions

Q: Which is the most effective antitubercular drug against slow multiplying intracellular mycobacteria?

Rifampicin. The effectiveness of antitubercular drugs (ATT) depends on their ability to target specific subpopulations of *Mycobacterium tuberculosis* based on their metabolic activity and location. **1. Why Rifampicin is correct:** Mycobacteria exist in four distinct populations. **Rifampicin** is unique because it is highly effective against **slowly multiplying organisms** (spurters) that reside within caseous material or intracellularly [1], [2]. It inhibits bacterial DNA-dependent RNA polymerase, exerting a potent bactericidal effect even during brief periods of metabolic activity [2]. This makes it the most important drug for preventing relapses (sterilizing action). **2. Why the other options are incorrect:** * **Isoniazid (INH):** While it is the most potent bactericidal drug, it is primarily effective against **rapidly multiplying** extracellular bacilli. It has minimal effect on slow growers. * **Pyrazinamide:** This drug is specifically active against bacilli in an **acidic medium** (intracellularly within macrophages). While it targets a specific niche, Rifampicin is considered more broadly effective against the "slowly multiplying" population across different environments. * **Ethambutol:** This is a **bacteriostatic** drug that inhibits cell wall synthesis. It is the least potent of the first-line drugs [3] and does not have significant sterilizing activity against slow growers. **High-Yield NEET-PG Pearls:** * **Best Sterilizing Action:** Rifampicin > Pyrazinamide. * **Early Bactericidal Activity (EBA):** Isoniazid (highest in the first 48 hours). * **Site of Action:** Pyrazinamide works best at acidic pH; Streptomycin works only at alkaline pH (extracellular). * **Mnemonic for Populations:** * **I**NH = **I**nside cavities (Rapidly growing). * **R**ifampicin = **R**esting/Slowly growing. * **P**yrazinamide = **P**hago-lysosomes (Acidic pH).

Q: Which of the following drugs requires dose adjustment in renal failure?

Streptomycin. **Explanation:** The primary determinant for dose adjustment in renal failure is the drug’s route of elimination. Drugs primarily excreted unchanged by the kidneys require dose reduction to prevent toxicity, whereas those eliminated via the liver (biliary/fecal) generally do not. **Why Streptomycin is Correct:** Streptomycin is an **Aminoglycoside**. Aminoglycosides are highly polar, water-soluble molecules that are excreted almost entirely (90%+) by glomerular filtration in their active form. In renal impairment, their clearance decreases proportionally to the decline in Creatinine Clearance (CrCl), leading to accumulation. This significantly increases the risk of **nephrotoxicity** and **ototoxicity**. Therefore, dose adjustment (either reducing the dose or lengthening the interval) is mandatory. **Why the Other Options are Incorrect:** * **Cefoperazone:** Unlike most cephalosporins, Cefoperazone (and Ceftriaxone) is primarily excreted through the **bile**. It does not require dose adjustment in renal failure but may require it in hepatic impairment. * **Doxycycline:** This is a unique tetracycline eliminated primarily via **fecal excretion** (chelated in the intestines). It is the tetracycline of choice in patients with renal failure. * **Rifampicin:** This is a highly lipid-soluble drug metabolized by the **liver** and excreted mainly through bile. It is safe to use in standard doses in patients with renal insufficiency. **High-Yield Clinical Pearls for NEET-PG:** * **"Safe" drugs in renal failure (No dose adjustment):** Doxycycline, Ceftriaxone, Cefoperazone, Rifampicin, Erythromycin, and Clindamycin. * **Aminoglycoside Rule:** Always monitor "Peak" levels for efficacy and "Trough" levels to minimize toxicity. * **Formula:** For drugs like Streptomycin, the new dose interval can be estimated as: *Normal Interval × (Patient’s Creatinine / Normal Creatinine).*

Q: Which of the following is a protease inhibitor?

Saquinavir. **Explanation:** The question tests the classification of Antiretroviral Therapy (ART) drugs used in the management of HIV. **Correct Option: B. Saquinavir** Saquinavir belongs to the **Protease Inhibitors (PIs)** class [5]. These drugs work by inhibiting the viral enzyme **HIV-1 protease** [4], which is responsible for cleaving precursor polyproteins (Gag-Pol) into functional mature proteins [1]. Inhibition of this enzyme results in the production of immature, non-infectious virions. * **High-Yield Tip:** All Protease Inhibitors typically end with the suffix **"-navir"** (e.g., Ritonavir, Atazanavir, Darunavir) [3]. **Incorrect Options:** * **A. Lamivudine (3TC):** This is a **Nucleoside Reverse Transcriptase Inhibitor (NRTI)**. It is a cytosine analog used in both HIV and Hepatitis B treatment. * **C. Delavirdine:** This is a **Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)** [2]. Unlike NRTIs, NNRTIs bind directly to the reverse transcriptase enzyme at a site different from the active site (allosteric inhibition). * **D. Zidovudine (AZT):** This is the prototype **NRTI** (thymidine analog). It is historically significant as the first drug approved for HIV and is notably used to prevent mother-to-child transmission. **Clinical Pearls for NEET-PG:** 1. **Metabolic Side Effects:** Protease Inhibitors are frequently associated with **lipodystrophy** (buffalo hump), hyperglycemia (insulin resistance), and hyperlipidemia. 2. **Ritonavir Boosting:** Ritonavir is a potent **CYP3A4 inhibitor** [5]. It is often used in low doses not for its antiviral effect, but to "boost" the plasma concentrations of other PIs. 3. **Indinavir:** A specific PI known for causing **nephrolithiasis** (crystalluria).

Q: What is the drug of choice for the treatment of chlamydial infection?

Doxycycline. The drug of choice for uncomplicated chlamydial infections (caused by *Chlamydia trachomatis*) is **Doxycycline**. [1] **1. Why Doxycycline is correct:** *Chlamydia trachomatis* is an obligate intracellular bacterium. Doxycycline, a tetracycline, is highly lipophilic, allowing it to penetrate host cell membranes effectively to reach the intracellular pathogen. It inhibits protein synthesis by binding to the 30S ribosomal subunit. Current CDC and WHO guidelines recommend Doxycycline (100 mg twice daily for 7 days) over Azithromycin due to superior efficacy in eradicating rectal and urogenital infections. [1] **2. Why the other options are incorrect:** * **Ampicillin & 3rd Gen Cephalosporins:** These are Beta-lactams that target the bacterial cell wall (peptidoglycan synthesis). Since *Chlamydia* lacks a classic peptidoglycan layer and resides intracellularly, these drugs are ineffective. * **Metronidazole:** This is an antiprotozoal and anaerobic antibacterial agent. It is used for *Trichomonas vaginalis* or Bacterial Vaginosis, but has no activity against *Chlamydia*. **3. High-Yield Clinical Pearls for NEET-PG:** * **Pregnancy:** Doxycycline is contraindicated in pregnancy (risk of fetal teeth discoloration/bone growth inhibition). The drug of choice for Chlamydia in pregnant women is **Azithromycin** (1g stat). * **Co-infection:** Patients with Gonorrhea are frequently co-infected with Chlamydia. Treatment often involves Ceftriaxone (for Gonorrhea) plus Doxycycline. [1] * **Lymphogranuloma Venereum (LGV):** Caused by *C. trachomatis* serotypes L1-L3; the treatment is also Doxycycline, but for a longer duration (21 days). * **Trachoma:** The WHO "SAFE" strategy uses a single dose of Azithromycin for mass drug administration.

Q: Which of the following anti-TB drugs requires an acidic medium for its action?

Pyrazinamide. ### Explanation **Correct Option: C. Pyrazinamide** Pyrazinamide (PZA) is a unique prodrug that requires conversion into its active form, **pyrazinoic acid**, by the bacterial enzyme *pyrazinamidase* [1]. This conversion and the subsequent accumulation of the drug within the mycobacteria occur most efficiently in an **acidic environment (pH 5.0–5.5)** [1]. In the body, this acidic medium is found within the **phagolysosomes of macrophages**, where *M. tuberculosis* organisms are often sequestered [1]. Because it targets intracellular bacilli in acidic environments, Pyrazinamide is highly effective against "slowly multiplying" or "persister" organisms, giving it a potent **sterilizing effect** that allows for the shortening of TB treatment from 9 months to 6 months. **Incorrect Options:** * **A. Isoniazid:** Acts by inhibiting mycolic acid synthesis. It is most effective against rapidly dividing extracellular bacilli and works best at a neutral pH. * **B. Rifampicin:** Inhibits DNA-dependent RNA polymerase. It is bactericidal against both intracellular and extracellular organisms and is relatively independent of pH for its primary mechanism. * **C. Ethambutol:** A bacteriostatic agent that inhibits arabinosyltransferase. It works best at a neutral pH and is primarily used to prevent the emergence of resistance. **High-Yield NEET-PG Pearls:** * **Site of Action:** Intracellular (Macrophage phagolysosomes). * **Most Common Side Effect:** Hyperuricemia (due to inhibition of uric acid excretion), which may precipitate acute gouty arthritis. * **Hepatotoxicity:** Pyrazinamide is considered the most hepatotoxic drug among the first-line anti-TB agents. * **Resistance:** Mutation in the *pncA* gene (which encodes pyrazinamidase) is the primary mechanism of resistance.

Q: Which cephalosporin is used to treat Pseudomonas aeruginosa infections?

Ceftazidime. **Explanation:** The correct answer is **Ceftazidime**. **1. Why Ceftazidime is correct:** Ceftazidime is a **3rd-generation cephalosporin** specifically distinguished by its potent activity against *Pseudomonas aeruginosa*. While most 3rd-generation cephalosporins focus on Gram-negative coverage, ceftazidime (along with the 4th-generation Cefepime) possesses a specific side chain that enhances its penetration through the outer membrane of *Pseudomonas* and increases its stability against its beta-lactamases. **2. Why the other options are incorrect:** * **Cefadroxil (Option A):** A **1st-generation** cephalosporin. It is primarily used for Gram-positive cocci (like *Staph* and *Strept*) and basic urinary tract infections (*E. coli*). It has no activity against *Pseudomonas*. * **Cefuroxime (Option B):** A **2nd-generation** cephalosporin. It offers improved Gram-negative coverage (e.g., *H. influenzae*) compared to the 1st generation but lacks the spectrum required to treat *Pseudomonas*. * **Cefotaxime (Option D):** A **3rd-generation** cephalosporin. While it has excellent coverage against most Gram-negative bacteria and is a drug of choice for bacterial meningitis, it is notoriously **inactive** against *Pseudomonas aeruginosa*. **3. Clinical Pearls for NEET-PG:** * **Anti-Pseudomonal Cephalosporins:** Remember the "3-4-5 rule": **Ceftazidime** (3rd gen), **Cefepime** (4th gen), and **Ceftobiprole/Ceftolozane** (5th gen). * **Ceftazidime Side Effect:** It is associated with a higher risk of inducing resistance (via AmpC beta-lactamases) and can rarely cause neurotoxicity/seizures in renal failure. * **Mnemonic:** "Taz" (Ceftazidime) and "Pime" (Cefepime) fight the "Pseudomonas" slime.

Q: Overexpression of the InhA gene can lead to cross-resistance of isoniazid with which of the following drugs?

Ethionamide. **Explanation:** The correct answer is **Ethionamide**. **Mechanism of Cross-Resistance:** Both Isoniazid (INH) and Ethionamide are prodrugs that inhibit mycolic acid synthesis in the mycobacterial cell wall. Their primary molecular target is the **InhA enzyme** (enoyl-ACP reductase). * **Isoniazid** is activated by the catalase-peroxidase enzyme (**KatG**). * **Ethionamide** is activated by the monooxygenase enzyme (**EthA**). While they require different enzymes for activation, they share the same final target (InhA). Resistance to Isoniazid can occur via two main mutations: 1. **KatG mutation:** Most common; causes high-level resistance to INH but *no* cross-resistance with Ethionamide. 2. **InhA overexpression/mutation:** Causes low-level resistance to INH and **cross-resistance with Ethionamide**, because the overexpressed target enzyme overwhelms both drugs. **Analysis of Incorrect Options:** * **A. Rifampicin:** Acts by inhibiting DNA-dependent RNA polymerase (*rpoB* gene mutation). It has no structural or target similarity with INH. * **B. Ethambutol:** Inhibits arabinosyl transferase (*embB* gene), interfering with arabinogalactan synthesis. * **D. PAS:** Inhibits dihydropteroate synthase, interfering with folate synthesis (similar to sulfonamides). **High-Yield Clinical Pearls for NEET-PG:** * **KatG mutation** is the most frequent cause of Isoniazid resistance. * **InhA mutation** is the specific mechanism that links INH resistance to Ethionamide resistance. * **Mnemonic:** "InhA" = **I**soniazid a**n**d **H**-ethionamide (Ethionamide). * Isoniazid is the drug of choice for Latent TB and Chemoprophylaxis. Its most common side effect is peripheral neuropathy (prevented by Vitamin B6/Pyridoxine).

Q: Which of the following is a bactericidal drug for Mycobacterium leprae?

Ofloxacin. ### Explanation **Correct Option: A. Ofloxacin** Ofloxacin is a fluoroquinolone that acts by inhibiting the enzyme **DNA gyrase (Topoisomerase II)**, preventing bacterial DNA replication. In the context of *Mycobacterium leprae*, Ofloxacin exhibits potent **bactericidal** activity. It is highly effective against the bacilli and is used as a component of alternative MDT (Multidrug Therapy) regimens, particularly in cases of Rifampicin resistance or intolerance. **Analysis of Incorrect Options:** * **B. Ciprofloxacin:** While also a fluoroquinolone, Ciprofloxacin has poor penetration into tissues for *M. leprae* and shows inconsistent activity compared to Ofloxacin. It is generally not used in standard leprosy protocols. * **C. Amoxicillin:** This is a beta-lactam antibiotic. *M. leprae* produces beta-lactamases, making most penicillins ineffective. Furthermore, cell wall synthesis inhibitors like Amoxicillin do not show significant bactericidal activity against the slow-growing leprosy bacilli. * **D. Erythromycin:** This macrolide is bacteriostatic for many organisms and has negligible activity against *M. leprae*. However, another macrolide, **Clarithromycin**, is highly bactericidal against *M. leprae* and is used in alternative regimens. **High-Yield Clinical Pearls for NEET-PG:** * **First-line Bactericidal Drugs for Leprosy:** Rifampicin (most potent), Ofloxacin, and Clarithromycin. * **Bacteriostatic Drugs for Leprosy:** Dapsone and Ethionamide. * **Clofazimine:** Primarily bacteriostatic but possesses weak bactericidal activity and important anti-inflammatory properties (useful in Type 2 Lepra reactions). * **ROM Regimen:** A single dose of **R**ifampicin (600 mg), **O**floxacin (400 mg), and **M**inocycline (100 mg) was previously used for Single Lesion Paucibacillary (SLPB) leprosy.

Question 1

Which is the most effective antitubercular drug against slow multiplying intracellular mycobacteria?

Accepted Answer

Rifampicin

Answer

Isoniazid

Answer

Pyrazinamide

Answer

Ethambutol

Question 2

A 55-year-old female was admitted to the ICU 8 days ago after suffering burns. Currently, she is febrile with a temperature of 102
F. Blood cultures were obtained, and the doctor is worried about a blood infection. The plan is to start empiric combination therapy containing aminoglycosides directed against Pseudomonas aeruginosa. The patient's old ultrasound record is available, but she could not come for follow-up due to lockdown. The doctor is concerned about the nephrotoxicity profile of the drugs. Which of the following drugs is the safest?

Accepted Answer

None of the above

Answer

Gentamicin

Answer

Tobramycin

Answer

Neomycin

Question 3

Which of the following drugs requires dose adjustment in renal failure?

Accepted Answer

Streptomycin

Answer

Cefoperazone

Answer

Doxycycline

Answer

Rifampicin

Question 4

Which of the following is a protease inhibitor?

Accepted Answer

Saquinavir

Answer

Lamivudine

Answer

Delavirdine

Answer

Zidovudine

Question 5

Which of the following is a true statement regarding Rifampicin?

Accepted Answer

Increased metabolism of cyclosporine when given concomitantly

Answer

Acts by inhibiting mycolic acid synthesis

Answer

Dose adjustment is needed in renal failure

Answer

Gets concentrated intracellularly mainly in neutrophils

Question 6

What is the drug of choice for the treatment of chlamydial infection?

Accepted Answer

Doxycycline

Answer

Ampicillin

Answer

Third generation cephalosporins

Answer

Metronidazole

Question 7

Which of the following anti-TB drugs requires an acidic medium for its action?

Accepted Answer

Pyrazinamide

Answer

Isoniazid

Answer

Rifampicin

Answer

Ethambutol

Question 8

Which cephalosporin is used to treat Pseudomonas aeruginosa infections?

Accepted Answer

Ceftazidime

Answer

Cefadroxil

Answer

Cefuroxime

Answer

Cefotaxime

Question 9

Overexpression of the InhA gene can lead to cross-resistance of isoniazid with which of the following drugs?

Accepted Answer

Ethionamide

Answer

Rifampicin

Answer

Ethambutol

Answer

Para-aminosalicylic acid (PAS)

Question 10

Which of the following is a bactericidal drug for Mycobacterium leprae?

Accepted Answer

Ofloxacin

Answer

Ciprofloxacin

Answer

Amoxicillin

Answer

Erythromycin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?